D.E. Shaw & Co’s Organon & Co OGN Stock Holding History

D.E. Shaw & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38,400	Closed	-$573K	–	4599
2024 Q4	$573K	Hold	38,400	–	–	﹤0.01%	3530
2024 Q3	$735K	Hold	38,400	–	–	﹤0.01%	3478
2024 Q2	$795K	Hold	38,400	–	–	﹤0.01%	3331
2024 Q1	$722K	Sell	38,400 -200,000	-84%	-$3.43M	﹤0.01%	3289
2023 Q4	$3.44M	Buy	+238,400	New	+$3.24M	﹤0.01%	2233
2023 Q3	–	Sell	-35,000	Closed	-$728K	–	4417
2023 Q2	$728K	Buy	+35,000	New	+$761K	﹤0.01%	3249
2022 Q1	–	Sell	-53,850	Closed	-$1.64M	–	5822
2021 Q4	$1.64M	Sell	53,850 -1,000	-2%	-$32.6K	﹤0.01%	3533
2021 Q3	$1.8M	Sell	54,850 -38,000	-41%	-$1.22M	﹤0.01%	3137
2021 Q2	$2.81M	Buy	+92,850	New	+$3.06M	﹤0.01%	2591

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

D.E. Shaw & Co's OGN Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Organon & Co (OGN) stake by 22% in Q1 2026, selling an estimated $5.58M and leaving 2,644,552 shares worth $15.8M. The position accounts for 0.01% of the portfolio, ranked #1299.

D.E. Shaw & Co first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $34.6M in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

D.E. Shaw & Co held 2,644,552 shares of Organon & Co worth $15.8M as of Q1 2026.
D.E. Shaw & Co sold 742,172 Organon & Co shares in Q1 2026, an estimated $5.58M.
Organon & Co made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1299 holding.
D.E. Shaw & Co first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
D.E. Shaw & Co's Organon & Co position peaked at $34.6M in Q2 2021.
603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.